Subscribe free

Newsletter

Intestine and Lower Gastrointestinal Tract

Every new paper in this field, in your inbox.

FreeNo spamOne-click unsubscribe
Ann Surg Open1 Oct 2024

Intraoperative factors improve prediction of hospital stay length

A new model predicting length of stay (LOS) after colorectal surgery demonstrates enhanced accuracy by including intraoperative risk factors. The intraoperative prediction model (IP model) achieved an area under the curve (AUC) of 0.84, outperforming the preoperative model (PP model) with an AUC of 0.75.…

Tech Coloproctol1 Oct 2024

Enhanced recovery protocols for colorectal surgery reduce complications and costs.

Implementation of an Enhanced Recovery After Surgery (ERAS) protocol significantly decreased infectious complications and postoperative hospital stays in colorectal cancer patients. In a matched study of 142 patients, ERAS yielded an 8.5% reduction in anastomotic dehiscence and surgical wound infections. Importantly, it was found to…

World J Surg30 Sep 2024

Elevated postoperative CEA levels indicate poor prognosis in CRC patients

A meta-analysis of 20 studies involving 10,114 colorectal cancer patients found that elevated postoperative carcinoembryonic antigen (CEA) levels significantly correlate with poorer overall survival, disease-free survival, and recurrence-free survival. Specifically, increased CEA levels were associated with hazard ratios indicating a roughly threefold decrease in survival…

Eur J Surg Oncol28 Sep 2024

Preoperative multidisciplinary team meetings improve survival in rectal cancer.

A population-based study in Catalonia analyzed 5,249 rectal cancer patients, revealing that those whose cases were discussed in preoperative multidisciplinary team meetings (MTMs) exhibited better 2-year survival rates. Specifically, the MTM group had a 22% increase in survival compared to those not discussed in such…

Int J Colorectal Dis28 Sep 2024

A new score predicts lymph node involvement in rectal cancer

A novel lateral pelvic lymph node positivity (LPLNP) score was developed to predict lymph node involvement in western rectal cancer patients. The score was validated on a cohort where 40 patients above a threshold of 0.23 underwent dissection, revealing a 55% positive confirmation rate. It…

Tech Coloproctol28 Sep 2024

Kono-S anastomosis significantly reduces postoperative recurrence in Crohn’s disease.

Kono-S anastomosis shows promising results in lowering recurrence rates for Crohn's disease patients undergoing surgery. In a systematic review and meta-analysis of 1,501 patients, endoscopic recurrence rates were 41% for Kono-S compared to 48% for conventional techniques, while surgical recurrence rates were remarkably lower at…

J Robot Surg27 Sep 2024

Robotic colectomy leads to better short-term oncologic outcomes.

Analysis of over 44,000 minimally invasive colectomy cases indicates that robotic techniques significantly enhance short-term oncologic results for colon cancer patients. Robotic colectomy correlated with nearly double the likelihood of chemotherapy initiation within 90 days (RR 1.98), more lymph nodes harvested, a 36% reduction in…

Ann Surg Treat Res26 Sep 2024

Wide hot snare polypectomy outperforms other methods for small tumors

In a study assessing salvage treatments for rectal neuroendocrine tumors (RNETs) under 10 mm, wide hot snare polypectomy (WHSP) showed superior outcomes. Of 121 patients analyzed, WHSP achieved an impressive 72.7% R0 resection rate compared to other methods. With a focus on effectiveness and safety,…

Ann Surg Oncol25 Sep 2024

PIPAC improves quality of life and survival in cancer treatment

The analysis demonstrated that patients receiving pressurized intraperitoneal aerosolized chemotherapy (PIPAC) experienced significantly more good days and reduced hospital stays compared to those treated with standard therapy (ST). Specifically, PIPAC patients had a median of 181 good days at six months versus 131 days for…

Surg Endosc25 Sep 2024

Outcomes for Colon Cancer Patients Vary by Facility Type

Surgical outcomes for colon cancer patients show significant variance based on facility type. Analysis of 125,935 patients revealed that those treated in academic/research programs (ARP) experienced the best median overall survival of 129 months, contrasting sharply with 103.7 months for community cancer programs (CCP). Additionally,…